Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meera Mohan

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|April 15, 2024
Risk stratification in multiple myeloma: Are we there yet?Meera Mohan, Carolina Schinke
Expert Review of Hematology|October 4, 2025
Stem cell boost for immune effector cell associated hematotoxicity in multiple myeloma: minimizing long-term complications and expanding post CAR T-cell therapy relapse optionsMeera Mohan, Carolina Schinke
JCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod Dhakal
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2020
Intractable hypercalcemia in a patient with multiple myeloma: An infectious etiologyJames Lopez, Mihir Raval, Meera Mohan
Cancers|October 13, 2021
The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple MyelomaMeera Mohan, Theresa Camille Maatman, Carolina Schinke
Cancer Management and Research|March 11, 2017
Update on the optimal use of bortezomib in the treatment of multiple myelomaMeera Mohan, Aasiya Matin, Faith E Davies
Current Oncology Reports|July 2, 2024
Current Status on Management of Primary Plasma Cell LeukemiaZimu Gong, Meera Khosla, Sreeraj Vasudevan, et al.
The American Journal of Case Reports|March 19, 2016
A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary PlasmacytomaMeera Mohan, Murat Gokden, Neriman Gokden, et al.
Expert Opinion on Biological Therapy|April 18, 2025
Addressing practical challenges with bispecific antibody therapy in multiple myelomaSreeraj Vasudevan, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Proceedings (Baylor University. Medical Center)|February 18, 2020
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphomaJames Lopez, Naveen Yarlagadda, Zaid Gheith, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|April 15, 2024
Risk stratification in multiple myeloma: Are we there yet?Meera Mohan, Carolina Schinke
Expert Review of Hematology|October 4, 2025
Stem cell boost for immune effector cell associated hematotoxicity in multiple myeloma: minimizing long-term complications and expanding post CAR T-cell therapy relapse optionsMeera Mohan, Carolina Schinke
JCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod Dhakal
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 6, 2020
Intractable hypercalcemia in a patient with multiple myeloma: An infectious etiologyJames Lopez, Mihir Raval, Meera Mohan
Cancers|October 13, 2021
The Role of Monoclonal Antibodies in the Era of Bi-Specifics Antibodies and CAR T Cell Therapy in Multiple MyelomaMeera Mohan, Theresa Camille Maatman, Carolina Schinke
Cancer Management and Research|March 11, 2017
Update on the optimal use of bortezomib in the treatment of multiple myelomaMeera Mohan, Aasiya Matin, Faith E Davies
Current Oncology Reports|July 2, 2024
Current Status on Management of Primary Plasma Cell LeukemiaZimu Gong, Meera Khosla, Sreeraj Vasudevan, et al.
The American Journal of Case Reports|March 19, 2016
A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary PlasmacytomaMeera Mohan, Murat Gokden, Neriman Gokden, et al.
Expert Opinion on Biological Therapy|April 18, 2025
Addressing practical challenges with bispecific antibody therapy in multiple myelomaSreeraj Vasudevan, Bhavesh Mohan Lal, Nikhil Vojjala, et al.
Proceedings (Baylor University. Medical Center)|February 18, 2020
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphomaJames Lopez, Naveen Yarlagadda, Zaid Gheith, et al.
Pageof 7